Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1696697

registered interest
date	18/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Skin Diseases: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the effectiveness of drugs available within the NHS to treat (a) epidermolysis bullosa and (b) other inflammatory skin conditions.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	18966
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) makes independent, evidence-based recommendations for the National Health Service on whether new licensed medicines should be routinely funded by the NHS, based on an assessment of their costs and benefits.</p><p>Currently, there is one product licensed specifically for epidermolysis bullosa, Filsuvez gel, which contains birch bark extract. The NICE recommends birch bark extract as a clinically and cost effective use of NHS resources, and the NHS is legally required to fund it in line with the NICE’s recommendations. Other healthcare products are also used in the care of epidermolysis bullosa patients. There are a number of licensed and NICE recommended treatments for other inflammatory skin conditions that are now routinely available for NHS patients.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 21/03/2024 12:21:44 answering member 4044 label Biography information for Andrew Stephenson
tabling member	242 label Biography information for Sir Christopher Chope

1696698

registered interest
date	18/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Trastuzumab Deruxtecan
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of the decision by the National Institute for Health and Care Excellence to not recommend trastuzumab deruxtecan for HER2-low secondary breast cancer for use on NHS on the life expectancy of eligible women.
tabling member constituency	North Warwickshire
tabling member printed	Craig Tracey
uin	19119
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) has not yet published final guidance on the use of trastuzumab deruxtecan (Enhertu) for the treatment of metastatic HER2-low breast cancer. The NICE published final draft guidance on 5 March 2024, that does not recommend it as a clinically and cost-effective use of National Health Service resources. Stakeholders had until 19 March 2024 to lodge an appeal against the NICE’s recommendations. The NICE currently expects to publish final guidance on 3 April 2024.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 21/03/2024 17:10:39 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4509 label Biography information for Craig Tracey

1696774

registered interest
date	18/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Health Professions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate she has made of the numbers of (a) Medical Physicists and (b) Clinical Engineers in the NHS Workforce as of 18 March 2024.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	19087
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>NHS England publishes monthly data on the numbers of National Health Service staff. This data is drawn from the Electronic Staff Record, the human resources system for the NHS, and is available at the following link:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-workforce-statistics" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-workforce-statistics</a></p><p>The number of healthcare scientists working within the care settings of Medical Physics and Clinical Engineering can be found in the NHS Workforce Statistics, November 2023 Staff Group, Care Setting and Level file, within the scientific, therapeutic, and technical staff, or ST&amp;T, tab.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 21/03/2024 12:24:23 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell

1696775

registered interest
date	18/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Health Professions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate she has made of the number of (a) Medical Physicists and (b) Clinical Engineers required in the NHS over the next (i) five (ii) 10 and (iii) 15 years.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	19088
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>NHS England does not hold data centrally on the requested information, although there are a range of estimates carried out by different groups.</p><p>The Diagnostic Imaging Networks have been encouraged to look at demand and capacity modelling at an integrated care board level.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 21/03/2024 17:20:43 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell

1696777

registered interest
date	18/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Health Professions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of recent advances in clinical (a) technology and (b) other equipment on the number of (i) medical physicists and (ii) clinical engineers that are required in the NHS.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	19090
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>The Department does not plan to make specific assessments of the impacts, but advances in clinical technology and equipment are crucial to the work of NHS England. For example, the Government has invested in the latest technology in radiotherapy, ensuring that every radiotherapy provider had access to modern, cutting-edge radiotherapy equipment, enabling the rollout of new techniques like stereotactic ablative radiotherapy. The total central investment made between 2016 and 2021 was £162 million, and enabled the replacement or upgrade of approximately 100 radiotherapy treatment machines.</p><p>The Department does not plan to make specific assessments of the number of medical physicists and clinical engineers required in the National Health Service, but is backing the NHS’s Long-Term Workforce Plan with over £2.4 billion of funding over the next five years, to ensure additional education and training places. We are also working with NHS England to reform and modernise the way staff work and harness new technology and innovations to double NHS labour productivity, and to make sure staff can spend more time with patients. Finally, NHS England is also growing the cancer workforce, with 50% more staff in the cancer workforce when compared to 2010.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 21/03/2024 12:31:31 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell

1696784

registered interest
date	18/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Professions: Regulation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what her Department's policy is on the regulation of clinical technologists.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	19097
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>Clinical Technologists are not regulated by law and the Government has no current plans to extend statutory regulation to the profession. The statutory regulation of healthcare professionals should only be used where the risks to public and patient protection cannot be addressed in other ways, such as through employer oversight or accredited voluntary registration.</p><p>The Government keeps the professions subject to statutory regulation under review and published a consultation, Healthcare regulation: deciding when statutory regulation is appropriate. The consultation ran from 6 January to 31 March 2022 and sought views on the criteria that should be used to determine when statutory regulation of a healthcare profession is appropriate. The Government will publish its response in due course.</p><p>The Department has not held any recent discussions with the Health and Care Professions Council on the registration of Clinical Technologists. The Professional Standards Authority (PSA) for health and social care’s Accredited Registers Programme independently assesses organisations who register practitioners who are not regulated by law. Healthcare scientists concerned with the practical application of physics, engineering, and technology are able to apply to join the register of Clinical Technologists, which is accredited by the PSA.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 19098 19099 question first answered 21/03/2024 14:33:08 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell

1696785

registered interest
date	18/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Professions: Registration
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will introduce a statutory register for (a) clinical technologists and (b) other health professionals that use a voluntary register.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	19098
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>Clinical Technologists are not regulated by law and the Government has no current plans to extend statutory regulation to the profession. The statutory regulation of healthcare professionals should only be used where the risks to public and patient protection cannot be addressed in other ways, such as through employer oversight or accredited voluntary registration.</p><p>The Government keeps the professions subject to statutory regulation under review and published a consultation, Healthcare regulation: deciding when statutory regulation is appropriate. The consultation ran from 6 January to 31 March 2022 and sought views on the criteria that should be used to determine when statutory regulation of a healthcare profession is appropriate. The Government will publish its response in due course.</p><p>The Department has not held any recent discussions with the Health and Care Professions Council on the registration of Clinical Technologists. The Professional Standards Authority (PSA) for health and social care’s Accredited Registers Programme independently assesses organisations who register practitioners who are not regulated by law. Healthcare scientists concerned with the practical application of physics, engineering, and technology are able to apply to join the register of Clinical Technologists, which is accredited by the PSA.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 19097 19099 question first answered 21/03/2024 14:33:08 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell

1696786

registered interest
date	18/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Professions: Registration
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she has had recent discussions with the Health and Care Professions Council on the registration of clinical technologists.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	19099
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>Clinical Technologists are not regulated by law and the Government has no current plans to extend statutory regulation to the profession. The statutory regulation of healthcare professionals should only be used where the risks to public and patient protection cannot be addressed in other ways, such as through employer oversight or accredited voluntary registration.</p><p>The Government keeps the professions subject to statutory regulation under review and published a consultation, Healthcare regulation: deciding when statutory regulation is appropriate. The consultation ran from 6 January to 31 March 2022 and sought views on the criteria that should be used to determine when statutory regulation of a healthcare profession is appropriate. The Government will publish its response in due course.</p><p>The Department has not held any recent discussions with the Health and Care Professions Council on the registration of Clinical Technologists. The Professional Standards Authority (PSA) for health and social care’s Accredited Registers Programme independently assesses organisations who register practitioners who are not regulated by law. Healthcare scientists concerned with the practical application of physics, engineering, and technology are able to apply to join the register of Clinical Technologists, which is accredited by the PSA.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 19097 19098 question first answered 21/03/2024 14:33:08 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell

1696815

registered interest
date	18/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Immunosuppression
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that (a) Evusheld 2 and (b) other covid-19 treatments for the immuno-compromised are available to patients.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	19190
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) makes recommendations on whether all new licensed medicines, including medicines for COVID-19, should be routinely funded by the National Health Service, based on an assessment of their costs and benefits. The NICE aims, wherever possible, to publish guidance close to licensing and the NHS in England is legally required to fund medicines recommended by the NICE, normally within three months of final guidance.</p><p>The NICE has published guidance that recommends three medicines, paxlovid, xevudy, and roactemra, for the treatment of COVID-19, both in the community and for patients in hospital. This guidance ensures that patients who are at the highest risk of developing severe disease from COVID-19 have access to clinically and cost-effective treatments.</p><p>The NICE has started its appraisal of sipavibart, which has been referred to as evusheld 2.0, through its standard processes, and its Appraisal Committee will meet to consider its recommendations in October 2024. The NICE will aim to publish its guidance as close as possible to licensing.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 19191 question first answered 21/03/2024 16:11:03 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4769 label Biography information for Daisy Cooper

1696816

registered interest
date	18/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Immunosuppression
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will have discussions with NICE on developing a fast track approval process for covid-19 treatments for the immuno-compromised.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	19191
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) makes recommendations on whether all new licensed medicines, including medicines for COVID-19, should be routinely funded by the National Health Service, based on an assessment of their costs and benefits. The NICE aims, wherever possible, to publish guidance close to licensing and the NHS in England is legally required to fund medicines recommended by the NICE, normally within three months of final guidance.</p><p>The NICE has published guidance that recommends three medicines, paxlovid, xevudy, and roactemra, for the treatment of COVID-19, both in the community and for patients in hospital. This guidance ensures that patients who are at the highest risk of developing severe disease from COVID-19 have access to clinically and cost-effective treatments.</p><p>The NICE has started its appraisal of sipavibart, which has been referred to as evusheld 2.0, through its standard processes, and its Appraisal Committee will meet to consider its recommendations in October 2024. The NICE will aim to publish its guidance as close as possible to licensing.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 19190 question first answered 21/03/2024 16:11:03 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4769 label Biography information for Daisy Cooper